{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:25:53Z","timestamp":1787869553218,"version":"build-2784847793"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Toxicol."],"abstract":"<jats:p>\n                    Inhaled particles can induce persistent pulmonary inflammation when macrophage-mediated clearance mechanisms are overwhelmed. Distinguishing particles that trigger biological activity through intrinsic toxicity from those acting primarily via particle overload represents a central challenge in inhalation toxicology and regulatory safety assessment. Mechanistically anchored new approach methodologies (NAMs) that capture key macrophage responses may therefore provide valuable tools for particle hazard identification while reducing reliance on animal testing. The alveolar macrophage assay (AMA) was developed as an\n                    <jats:italic>in vitro<\/jats:italic>\n                    method to assess particle-induced macrophage activation using four biological endpoints reflecting oxidative stress, lysosomal activation, cytotoxicity, and inflammatory signaling. Previous work demonstrated predictivity of the AMA for short-term inhalation outcomes of nanomaterials. However, broader application of the method requires evidence that the assay can be reliably transferred across laboratories and produce reproducible results with a wide variety of particles. In the present study, an interlaboratory ring-study was conducted to evaluate the transferability and reproducibility of the AMA. Twelve blinded particles were tested in three independent laboratories using standardized protocols and predefined acceptance criteria. Across laboratories, comparable dose-response patterns were observed for most endpoints, and seven of the twelve particles were consistently classified as either biologically active or passive according to the established data interpretation procedure (DIP). Sources of variability were identified, including differences in assay sensitivity, and limitations related to dose metrics and partially soluble particles. A main source of variability was the fetal bovine serum (FBS), highlighting the urgent need for transition to animal-component-free and chemically defined culture media to improve reproducibility of\n                    <jats:italic>in vitro<\/jats:italic>\n                    methods. Taken together, the results demonstrate that the AMA can be successfully transferred across laboratories and generate reproducible biological responses when strict standardization and quality criteria are applied, which underlines the importance of good\n                    <jats:italic>in vitro<\/jats:italic>\n                    method practice (GIVIMP). These findings represent an important step toward the validation of the AMA and support its use as a NAM for mechanism-based hazard assessment and grouping of particles in inhalation toxicology.\n                  <\/jats:p>","DOI":"10.3389\/ftox.2026.1844090","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:10:08Z","timestamp":1787868608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Readiness of the in vitro alveolar macrophage assay: an interlaboratory comparison using 12 blinded particles"],"prefix":"10.3389","volume":"8","author":[{"given":"Emanoela","family":"Th\u00e1","sequence":"first","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology","place":["Ludwigshafen am Rhein, Germany"]},{"name":"Free University of Berlin, Pharmacy, Pharmacology and Toxicology","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Vennemann","sequence":"additional","affiliation":[{"name":"IBE R&D Institute for Lung Health gGmbH","place":["M\u00fcnster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Marani","sequence":"additional","affiliation":[{"name":"LIST, Luxembourg Institute of Science and Technology","place":["Esch-sur-Alzette, Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Gr\u00e4b","sequence":"additional","affiliation":[{"name":"IBE R&D Institute for Lung Health gGmbH","place":["M\u00fcnster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Verlohner","sequence":"additional","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology","place":["Ludwigshafen am Rhein, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma-Hock","sequence":"additional","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology","place":["Ludwigshafen am Rhein, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inka Marie","family":"Spyridonov","sequence":"additional","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology","place":["Ludwigshafen am Rhein, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamina","family":"Weber","sequence":"additional","affiliation":[{"name":"LIST, Luxembourg Institute of Science and Technology","place":["Esch-sur-Alzette, Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Chary","sequence":"additional","affiliation":[{"name":"LIST, Luxembourg Institute of Science and Technology","place":["Esch-sur-Alzette, Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Serchi","sequence":"additional","affiliation":[{"name":"LIST, Luxembourg Institute of Science and Technology","place":["Esch-sur-Alzette, Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Landsiedel","sequence":"additional","affiliation":[{"name":"BASF SE, Experimental Toxicology and Ecology","place":["Ludwigshafen am Rhein, Germany"]},{"name":"Free University of Berlin, Pharmacy, Pharmacology and Toxicology","place":["Berlin, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wiemann","sequence":"additional","affiliation":[{"name":"IBE R&D Institute for Lung Health gGmbH","place":["M\u00fcnster, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","article-title":"A new look at the statistical model identification","volume":"19","author":"Akaike","year":"1974","journal-title":"IEEE Trans. Automatic Control"},{"key":"B2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.yrtph.2015.03.007","article-title":"A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping)","volume":"71","author":"Arts","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.yrtph.2015.11.020","article-title":"Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice","volume":"76","author":"Arts","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"100524","DOI":"10.1016\/j.impact.2024.100524","article-title":"Overview of in vitro-in vivo extrapolation approaches for the risk assessment of nanomaterial toxicity","volume":"35","author":"Azizah","year":"2024","journal-title":"NanoImpact"},{"key":"B5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.14573\/altex.1712081","article-title":"Recommendation on test readiness criteria for new approach methods in toxicology: exemplified for developmental neurotoxicity","volume":"35","author":"Bal-Price","year":"2018","journal-title":"ALTEX"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12989-015-0086-4","article-title":"Lung particle overload: old school -new insights?","volume":"12","author":"Borm","year":"2015","journal-title":"Part Fibre Toxicol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"104498","DOI":"10.1016\/j.yrtph.2019.104498","article-title":"Pulmonary toxicity in rats following inhalation exposure to poorly soluble particles: the issue of impaired clearance and the relevance for human health hazard and risk assessment","volume":"109","author":"Bos","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1743-8977-11-18","article-title":"Physicochemical characteristics of nanomaterials that affect pulmonary inflammation","volume":"11","author":"Braakhuis","year":"2014","journal-title":"Part Fibre Toxicol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/oem.50.9.797","article-title":"Toxicological investigations on silicon carbide. 1. Inhalation studies","volume":"50","author":"Bruch","year":"","journal-title":"Br. J. Ind. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/oem.50.9.807","article-title":"Toxicological investigations on silicon carbide. 2. in vitro cell tests and long term injection tests","volume":"50","author":"Bruch","year":"","journal-title":"Br. J. Ind. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3109\/08958378.2014.885099","article-title":"Toxicological investigations on the respirable fraction of silicon carbide grain products by the in vitro vector model","volume":"26","author":"Bruch","year":"2014","journal-title":"Inhal. Toxicol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1163\/016942409X12598231567862","article-title":"How substrate properties control cell adhesion. A physical\u2013chemical approach","volume":"24","author":"Carr\u00e9","year":"2010","journal-title":"J. Adhesion Sci. Technol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.tiv.2017.12.011","article-title":"Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: an international workshop report","volume":"48","author":"Clippinger","year":"2018","journal-title":"Toxicol Vitro"},{"key":"B14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.14573\/altex.2401041","article-title":"Elements and development processes for test methods in toxicology and human health-relevant life science research","volume":"41","author":"C\u00f6llen","year":"2024","journal-title":"ALTEX"},{"key":"B15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12989-021-00419-w","article-title":"Retained particle surface area dose drives inflammation in rat lungs following acute, subacute, and subchronic inhalation of nanomaterials","volume":"18","author":"Cosnier","year":"2021","journal-title":"Part Fibre Toxicol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"00859","DOI":"10.1183\/23120541.00859-2024","article-title":"A comprehensive evaluation of murine and human ex vivo cultured alveolar macrophages","volume":"11","author":"David","year":"2025","journal-title":"ERJ Open Res."},{"key":"B17","unstructured":"Grenzwerte Staub: stoffspezifische Regelungen und ASGW als allgemeine Obergrenze; Hinweise zu St\u00e4uben mit spezifischer Toxizit\u00e4t\n          \n          \n          2020"},{"key":"B18","volume-title":"Allgemeiner Staubgrenzwert (ASGW): Anwendung Und Geltungsbereich (TRGS 900)","year":"2023"},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1743-8977-9-13","article-title":"A short history of the toxicology of inhaled particles","volume":"9","author":"Donaldson","year":"2012","journal-title":"Part Fibre Toxicol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4997\/jrcpe.2017.317","article-title":"James craufurd gregory, 19Th century Scottish physicians, and the link between occupation as a coal miner and lung disease","volume":"47","author":"Donaldson","year":"2017","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"B21","doi-asserted-by":"publisher","first-page":"907318","DOI":"10.3389\/fpubh.2022.907318","article-title":"Review of lung particle overload, rat lung cancer, and the conclusions of the Edinburgh expert panel-it\u2019s time to revisit cancer hazard classifications for titanium dioxide and carbon black","volume":"10","author":"Driscoll","year":"2022","journal-title":"Front. Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/08958378.2020.1735581","article-title":"Expert workshop on the hazards and risks of poorly soluble low toxicity particles","volume":"32","author":"Driscoll","year":"2020","journal-title":"Inhal. Toxicol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/10618600.1996.10474708","article-title":"Randomized quantile residuals","volume":"5","author":"Dunn","year":"1996","journal-title":"J. Comput. Graph. Statistics"},{"key":"B24","article-title":"Poorly Soluble Particles\/Lung Overload. Technical Report No. 122\u201d","year":"2013"},{"key":"B25","article-title":"Horizon 2020 work programme 2014\u20132015: general annexes. G. technology readiness levels (TRL)","volume-title":"Extract from Part 19 - Commission Decision C(2014)4995","year":"2014"},{"key":"B26","volume-title":"Article 25 of Regulation (EC) No 1907\/2006 of the European Parliament and of the Council of 18 December 2006 Concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Establishing a European Chemicals Agency, Amending Directive 1999\/45\/EC and Repealing Council Regulation (EEC) No 793\/93 and Commission Regulation (EC) No 1488\/94 as Well as Council Directive 76\/769\/EEC and Commission Directives 91\/155\/EEC, 93\/67\/EEC, 93\/105\/EC and 2000\/21\/EC\u201d, In: 02006R1907","year":"2025"},{"key":"B27","volume-title":"Workplace Atmospheres - Size Fraction Definitions for Measurement of Airborne Particles","year":"1993"},{"key":"B28","volume-title":"Nanoreg Framework for the Safety Assessment of Nanomaterials","author":"Gottardo","year":"2017"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1431790","DOI":"10.3389\/ftox.2024.1431790","article-title":"New approach methodologies (NAMs) for the in vitro assessment of cleaning products for respiratory irritation: workshop report","volume":"6","author":"Haber","year":"2024","journal-title":"Front. Toxicol."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.32614\/CRAN.package.DHARMa","article-title":"DHARMa: residual diagnostics for hierarchical (Multi-Level\/mixed) regression models","author":"Hartig","year":"2024","journal-title":"R. Package Version.0.4.7"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.34865\/mb742990vere5_3ad","article-title":"\u03b1-Aluminium oxide (corundum) (respirable fraction). MAK value documentation, supplement- translation of the German version from 2019","volume":"5","author":"Hartwig","year":"2020","journal-title":"MAK Collect. Occup. Health Saf."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00204-024-03736-z","article-title":"Avoiding a reproducibility crisis in regulatory toxicology-on the fundamental role of ring trials","volume":"98","author":"Jacobs","year":"2024","journal-title":"Arch. Toxicol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1080\/17435390.2021.1946186","article-title":"Creating sets of similar nanoforms with the ECETOC NanoApp: real-life case studies","volume":"15","author":"Janer","year":"","journal-title":"Nanotoxicology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1080\/17435390.2020.1842933","article-title":"Rationale and decision rules behind the ECETOC NanoApp to support registration of sets of similar nanoforms within REACH","volume":"15","author":"Janer","year":"","journal-title":"Nanotoxicology"},{"key":"B35","article-title":"Final protocol for producing suitable manufactured nanomaterial exposure media: the generic NANOGENOTOX dispersion protocol","volume-title":"Towards a Method for Detecting the Potential Genotoxicity of Nanomaterials the National Research Centre for the Working Environment","author":"Jensen","year":"2011"},{"key":"B36","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41598-019-56872-3","article-title":"Predicting dissolution and transformation of inhaled nanoparticles in the lung using abiotic flow cells: the case of barium sulfate","volume":"10","author":"Keller","year":"2020","journal-title":"Sci. Rep."},{"key":"B37","article-title":"A comparison between in vitro responses of human alveolar macrophage-like cells (ImmuPHAGE\u2122) and rat alveolar macrophages (NR8383) for predicting short-term inhalation toxicity of particles","volume":"204","author":"Kelsall","year":"2025","journal-title":"The Toxicologist, Supplement to Toxicological Sciences"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00204-012-0834-2","article-title":"Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies","volume":"86","author":"Klein","year":"2012","journal-title":"Arch. Toxicol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.impact.2018.08.005","article-title":"Abiotic dissolution rates of 24 (nano)forms of 6 substances compared to macrophage-assisted dissolution and in vivo pulmonary clearance: grouping by biodissolution and transformation","volume":"12","author":"Koltermann-J\u00fclly","year":"2018","journal-title":"NanoImpact"},{"key":"B40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12989-014-0055-3","article-title":"Biokinetics and effects of barium sulfate nanoparticles","volume":"11","author":"Konduru","year":"2014","journal-title":"Part Fibre Toxicol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1289\/ehp.97105s51261","article-title":"Cell size of alveolar macrophages: an interspecies comparison","volume":"105","author":"Krombach","year":"1997","journal-title":"Environ. Health Perspect."},{"key":"B42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1743-8977-11-16","article-title":"Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials","volume":"11","author":"Landsiedel","year":"2014","journal-title":"Part Fibre Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/aivt.2023.0018","article-title":"The use of toxicokinetic information for setting concentrations of in vitro toxicity tests and for interpreting their results: a proposed workflow","volume":"10","author":"Landsiedel","year":"2024","journal-title":"Appl. Vitro Toxicol."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.32614\/CRAN.package.emmeans","article-title":"Emmeans: estimated marginal means, aka least-squares means","author":"Lenth","year":"2025","journal-title":"R package version 2.0.1"},{"key":"B45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12989-022-00507-5","article-title":"A comprehensive understanding of ambient particulate matter and its components on the adverse health effects based from epidemiological and laboratory evidence","volume":"19","author":"Li","year":"2022","journal-title":"Part Fibre Toxicol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"eadx8586","DOI":"10.1126\/sciadv.adx8586","article-title":"Alveolar macrophages initiate the spatially targeted recruitment of neutrophils after nanoparticle inhalation","volume":"11","author":"Liu","year":"2025","journal-title":"Sci. Adv."},{"key":"B47","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.21105\/joss.03139","article-title":"Performance: an R package for assessment, comparison and testing of statistical models","volume":"6","author":"L\u00fcdecke","year":"2021","journal-title":"J. Open Source Softw."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e2005725","DOI":"10.1002\/smll.202005725","article-title":"The use of nanomaterial in vivo organ burden data for in vitro dose setting","volume":"17","author":"Ma-Hock","year":"2021","journal-title":"Small"},{"key":"B49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12989-026-00670-z","article-title":"A quantitative definition for poorly soluble particles","volume":"23","author":"Ma-Hock","year":"2026","journal-title":"Part Fibre Toxicol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"8163","DOI":"10.1038\/s41598-019-44551-2","article-title":"Fate of barium sulfate nanoparticles deposited in the lungs of rats","volume":"9","author":"Molina","year":"2019","journal-title":"Sci. Rep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0272-0590(88)90284-9","article-title":"Possible mechanisms to explain dust overloading of the lungs","volume":"10","author":"Morrow","year":"1988","journal-title":"Fundam. Appl. Toxicol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0041-008X(92)90002-A","article-title":"Dust overloading of the lungs: update and appraisal","volume":"113","author":"Morrow","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B53","volume-title":"Technology Readiness Level Definitions","year":"2017"},{"key":"B54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/jam.1988.1.289","article-title":"Lung clearance of inhaled insoluble and soluble particles","volume":"1","author":"Oberd\u00f6rster","year":"1988","journal-title":"J. Aerosol Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/02726359608906690","article-title":"Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles","volume":"14","author":"Oberd\u00f6rster","year":"1996","journal-title":"Particul. Sci. Technol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1289\/ehp.97-1519541","article-title":"Role of the alveolar macrophage in lung injury: studies with ultrafine particles","volume":"97","author":"Oberd\u00f6rster","year":"1992","journal-title":"Environ. Health Perspect."},{"key":"B57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles","volume":"113","author":"Oberd\u00f6rster","year":"2005","journal-title":"Environ. Health Perspect."},{"key":"B58","volume-title":"Guidance Document on Good in Vitro Method Practices (GIVIMP)OECD Series on Testing and Assessment","year":"2018"},{"key":"B59","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbagen.2016.09.031","article-title":"Quantitative analysis of the role of fiber length on phagocytosis and inflammatory response by alveolar macrophages","volume":"1861","author":"Padmore","year":"2017","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"B60","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1093\/toxsci\/kfp046","article-title":"Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size","volume":"109","author":"Pauluhn","year":"2009","journal-title":"Toxicol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1016\/j.tox.2010.10.009","article-title":"Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation","volume":"279","author":"Pauluhn","year":"2011","journal-title":"Toxicology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12989-014-0072-2","article-title":"Derivation of occupational exposure levels (OELs) of low-toxicity isometric biopersistent particles: how can the kinetic lung overload paradigm be used for improved inhalation toxicity study design and OEL-derivation?","volume":"11","author":"Pauluhn","year":"2014","journal-title":"Part Fibre Toxicol."},{"key":"B63","volume-title":"R: A Language and Environment for Statistical Computing","year":"2025"},{"key":"B64","first-page":"181","article-title":"Ein neues in vitro-Pr\u00fcfkonzept (Vektorenmodell) zum biologischen Screening und Monitoring der Lungentoxicit\u00e4t von St\u00e4uben","volume":"59","author":"Rehn","year":"1999","journal-title":"Gefahrst. - Reinhalt. Luft"},{"key":"B65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12989-019-0302-8","article-title":"Particle toxicology and health - where are we?","volume":"16","author":"Riediker","year":"2019","journal-title":"Part Fibre Toxicol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","article-title":"Dose-response analysis using R","volume":"10","author":"Ritz","year":"2016","journal-title":"PLOS ONE"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1664209","DOI":"10.3389\/ftox.2025.1664209","article-title":"Revisiting 3Rs: rethinking replacement and new approach methodologies","volume":"7","author":"Rosolowski","year":"2025","journal-title":"Front. Toxicol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1743-8977-5-17","article-title":"Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area","volume":"5","author":"Sager","year":"2008","journal-title":"Part Fibre Toxicol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.1016\/j.toxlet.2025.07.895","article-title":"P30-34 scalable generation and use of human alveolar-like macrophages to standardize inhalation toxicology and pulmonary immune response","volume":"411","author":"Schinke","year":"2025","journal-title":"Toxicol. Lett."},{"key":"B70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jaerosci.2015.12.006","article-title":"Surface area is the biologically most effective dose metric for acute nanoparticle toxicity in the lung","volume":"99","author":"Schmid","year":"2016","journal-title":"J. Aerosol Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/13547500902965617","article-title":"Dosimetry and toxicology of inhaled ultrafine particles","volume":"14","author":"Schmid","year":"2009","journal-title":"Biomarkers"},{"key":"B72","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1016\/j.toxlet.2025.07.435","article-title":"P17-07 in vitro approaches for inhalation safety assessment of poorly soluble and insoluble materials","volume":"411","author":"Scott","year":"2025","journal-title":"Toxicol. Lett."},{"key":"B73","doi-asserted-by":"publisher","first-page":"e07293","DOI":"10.1002\/smll.202507293","article-title":"Deciphering the heterogeneity of pulmonary macrophages in response to fine particles","volume":"22","author":"Shan","year":"2026","journal-title":"Small"},{"key":"B74","doi-asserted-by":"publisher","first-page":"104988","DOI":"10.1016\/j.yrtph.2021.104988","article-title":"Classes of organic pigments meet tentative PSLT criteria and lack toxicity in short-term inhalation studies","volume":"124","author":"Stratmann","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"964553","DOI":"10.3389\/ftox.2022.964553","article-title":"Use of new approach methodologies (NAMs) to meet regulatory requirements for the assessment of industrial chemicals and pesticides for effects on human health","volume":"4","author":"Stucki","year":"2022","journal-title":"Front. Toxicol."},{"key":"B76","volume-title":"In vivo","author":"Takebayashi","year":"2019"},{"key":"B77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12989-024-00572-y","article-title":"Toxicological inhalation studies in rats to substantiate grouping of zinc oxide nanoforms","volume":"21","author":"Thoma","year":"2024","journal-title":"Part Fibre Toxicol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"99","DOI":"10.14573\/altex.1705101","article-title":"Fetal serum (FBS): past - present - future","volume":"35","author":"van der Valk","year":"2018","journal-title":"ALTEX"},{"key":"B79","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00418-017-1571-7","article-title":"Initial cell adhesion of three cell types in the presence and absence of serum proteins","volume":"148","author":"Verdanova","year":"2017","journal-title":"Histochem Cell Biol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1612903","DOI":"10.3389\/ftox.2025.1612903","article-title":"Fetal bovine serum: how to leave it behind in the pursuit of more reliable science","volume":"7","author":"Weber","year":"2025","journal-title":"Front. Toxicol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12951-016-0164-2","article-title":"An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials","volume":"14","author":"Wiemann","year":"2016","journal-title":"J. Nanobiotechnology"},{"key":"B82","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/026119290102900210","article-title":"The importance of the prediction model in the validation of alternative tests","volume":"29","author":"Worth","year":"2001","journal-title":"Altern. Laboratory Animals"},{"key":"B83","first-page":"116","article-title":"Usher Staubinhalationskrankeheiten der Lungen","volume":"2","author":"Zenker","year":"1867","journal-title":"Dtsch. Arch. Klin. Med."}],"container-title":["Frontiers in Toxicology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1844090\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:10:12Z","timestamp":1787868612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/ftox.2026.1844090\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":83,"alternative-id":["10.3389\/ftox.2026.1844090"],"URL":"https:\/\/doi.org\/10.3389\/ftox.2026.1844090","relation":{},"ISSN":["2673-3080"],"issn-type":[{"value":"2673-3080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1844090"}}